Search Results 721-730 of 17541 for treatment resistant depression
Several clinical and research programs at Mayo Clinic are examining strategies to improve the delivery of evidence-based mental health treatments.
Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the activated B-cell (ABC) type ...
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix, ...
The purpose of this Phase 1a/1b study of SC-003 in patients with platinum-resistant/refractory ovarian cancer is to characterize the safety and tolerability of ...
Open the child-resistant cap on the bottle by ... coma; constipation; continuing vomiting; convulsions; dark-colored urine; decreased urine output; depression ...
— A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an ...
By condition, treatment or drug name. Search tips. Effects of Symptom Severity, Depressive and Anxiety Symptoms, and Health Behaviors on Daily Functioning and ...
A Study to Compare HF10 Therapy Combined with Conventional Medical Management (CMM) to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain · Overview.
Long-lasting condition can include heart disease, diabetes, depression, or back or joint pain. It's important to talk to a health care provider before starting ...
A Study Of Acute Stimulation For The Modulation Of Epileptic Events With A Closed-Loop Brain Interchange System In Drug Resistant Epilepsy. Rochester, Minn ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!